HCW Biologics Inc (HCWB)

[Frankestin]

The science is pointing toward IL-7/IL-15/IL-21 as the future of CAR-T — and HCW already has a product built around it.
The real upside isn’t selling a single reagent, but capturing a share of the growing CAR-T reagent market by embedding HCW9206 into manufacturing workflows — where even modest adoption could translate into meaningful recurring revenues, in-house or through licensing.
Why keep it under $1?

https://link.springer.com/article/10.1007/s00262-024-03765-8
https://www.science.org/doi/10.1126/sciadv.aec2632